Global Preclinical CRO Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Preclinical CRO Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
Global Preclinical CRO Treatment market is projected to reach US$ 1612.8 million in 2029, increasing from US$ 714.3 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029. Demand from Biopharmaceutical Companies and Government and Academic Institutes are the major drivers for the industry.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preclinical CRO Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Preclinical CRO Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Preclinical CRO Treatment introduction, etc. Preclinical CRO Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Preclinical CRO Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Preclinical CRO Treatment market is projected to reach US$ 1612.8 million in 2029, increasing from US$ 714.3 million in 2022, with the CAGR of 12.2% during the period of 2024 to 2029. Demand from Biopharmaceutical Companies and Government and Academic Institutes are the major drivers for the industry.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preclinical CRO Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Preclinical CRO Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Preclinical CRO Treatment introduction, etc. Preclinical CRO Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Preclinical CRO Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices